Zusammenfassung
Diabetesprävention kann durch Lebensstilintervention, Pharmakotherapie oder eine Kombination aus beiden erreicht werden. In einer Vielzahl von wegweisenden randomisierten, kontrollierten Studien wurde festgestellt, dass Präventionsprogramme das Typ-2-Diabetes-Risiko während der Interventionsphase effektiv senken und in den Jahren danach niedrig halten. Darüber hinaus wurde in diesen Untersuchungen auch eine Reduktion weiterer Morbiditätsrisiken, wie des Risikos kardiovaskulärer und maligner Erkrankungen, nachgewiesen. In vorliegender Übersichtsarbeit soll ein Überblick über die Langzeitergebnisse mehrere Jahre nach Abschluss von Diabetespräventionsprogrammen gegeben werden.
Abstract
Diabetes prevention can be achieved through lifestyle intervention, pharmacotherapy, or a combination of both. A large number of pioneering, randomized controlled studies have shown that prevention programs can effectively reduce the risk of type 2 diabetes during the intervention phase and keep it low in the years after the intervention. In addition, these studies have also shown a reduction in other morbidity risks, such as the risk of cardiovascular diseases and cancer. The goal of this review is to provide a review of the long-term results several years after the end of diabetes prevention programs.
Literatur
Diabetes Prevention Program Research Group (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677–1686. https://doi.org/10.1016/S0140-6736(09)61457-4
Gong Q, Zhang P, Wang J et al (2019) Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 7:452–461. https://doi.org/10.1016/S2213-8587(19)30093-2
Haw JS, Galaviz KI, Straus AN et al (2017) Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 177:1808. https://doi.org/10.1001/jamainternmed.2017.6040
Hemmingsen B, Gimenez-Perez G, Mauricio D et al (2017) Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003054.pub4
Irwin ML (2006) Randomized controlled trials of physical activity and breast cancer prevention. Exerc Sport Sci Rev 34:182–193. https://doi.org/10.1249/01.jes.0000240026.15126.ca
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403. https://doi.org/10.1056/nejmoa012512
Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67:152–162. https://doi.org/10.1016/j.diabres.2004.06.010
Li G, Zhang P, Wang J et al (2014) Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2:474–480. https://doi.org/10.1016/S2213-8587(14)70057-9
Li Y, Schoufour J, Wang DD et al (2020) Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.l6669
Lindahl B, Nilssön TK, Borch-Johnsen K et al (2009) A randomized lifestyle intervention with 5‑year follow-up in subjects with impaired glucose tolerance: Pronounced short-term impact but long-term adherence problems. Scand J Public Health 37:434–442. https://doi.org/10.1177/1403494808101373
Lindström J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679. https://doi.org/10.1016/S0140-6736(06)69701-8
Lindström J, Peltonen M, Eriksson JG et al (2013) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:284–293. https://doi.org/10.1007/s00125-012-2752-5
Ma C, Avenell A, Bolland M et al (2017) Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. https://doi.org/10.1136/bmj.j4849
Orchard TJ, Temprosa M, Barrett-Connor E et al (2013) Long-term effects of the diabetes prevention program interventions on cardiovascular risk factors: a report from the DPP outcomes study. Diabet Med 30:46–55. https://doi.org/10.1111/j.1464-5491.2012.03750.x
Pan X‑R, Li G‑W, Hu Y‑H et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care 20:537–544. https://doi.org/10.2337/diacare.20.4.537
Perreault L, Kahn SE, Christophi CA et al (2009) Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32:1583–1588. https://doi.org/10.2337/dc09-0523
Ramachandran A, Snehalatha C, Mary S et al (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297. https://doi.org/10.1007/s00125-005-0097-z
Roumen C, Corpeleijn E, Feskens EJM et al (2008) Impact of 3‑year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabet Med 25:597–605. https://doi.org/10.1111/j.1464-5491.2008.02417.x
Schellenberg ES, Dryden DM, Vandermeer B et al (2013) Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159:543. https://doi.org/10.7326/0003-4819-159-8-201310150-00007
Schmid V, Wagner R, Sailer C et al (2017) Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. Diabetologia 60:2341–2351. https://doi.org/10.1007/s00125-017-4407-z
Shah AD, Langenberg C, Rapsomaniki E et al (2015) Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol 3:105–113. https://doi.org/10.1016/S2213-8587(14)70219-0
Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350. https://doi.org/10.1056/NEJM200105033441801
Uusitupa M, Khan TA, Viguiliouk E et al (2019) Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis. Nutrients 11:2611. https://doi.org/10.3390/nu11112611
Yoon U, Kwok LL, Magkidis A (2013) Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 62:303–314. https://doi.org/10.1016/j.metabol.2012.07.009
Zhang Y, Pan X‑F, Chen J et al (2020) Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Diabetologia 63:21–33. https://doi.org/10.1007/s00125-019-04985-9
den Boer AT AT, Herraets IJ, Stegen J et al (2013) Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study. Nutr Metab Cardiovasc Dis. https://doi.org/10.1016/j.numecd.2012.12.005
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Dannecker, J. Hummel und L. Fritsche geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Dannecker, C., Hummel, J. & Fritsche, L. Langzeiteffekte von Diabetespräventionsmaßnahmen. Diabetologe 16, 215–219 (2020). https://doi.org/10.1007/s11428-020-00593-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-020-00593-z